🔎 Trials Near Me

Dachaigh › Myelofibrosis › Alabama › Birmingham

Sgrùdaidhean clionaigeach Myelofibrosis ann an Birmingham, AL

Tha 7 sgrùdaidhean airson Myelofibrosis a’ lorg phàirtichean aig làraichean ann agus timcheall air Birmingham (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

A’ fastadhÌre 1/2
  • University of Alabama, Birmingham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04176198

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

A’ fastadhÌre 1
  • University of Alabama At Birmingham, Birmingham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT07441694

UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy

A’ fastadhÌre 1
  • University of Alabama at Birmingham, Birmingham
4 Weeks – 75 Years · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT06047886

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

A’ fastadhSgrùdadh amharc
  • Massive Bio SYNERGY-AI site, Birmingham
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

A’ fastadhÌre 3
  • UAB Hospital, Birmingham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2025 · NCT06479135

Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

A’ fastadhÌre 1/2
  • University of Alabama at Birmingham, Birmingham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Gearr 2023 · NCT05280509

Sgrùdaidhean Myelofibrosis ann am bailtean eile

Sgrùdaidhean eile ann an Birmingham

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.